pHAGE-KDR Citations (2)
Originally described in: Systematic Functional Annotation of Somatic Mutations in Cancer.Ng PK, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana VH, Tran R, Soewito S, Minussi DC, Moreno D, Kong K, Dogruluk T, Lu H, Gao J, Tokheim C, Zhou DC, Johnson AM, Zeng J, Ip CKM, Ju Z, Wester M, Yu S, Li Y, Vellano CP, Schultz N, Karchin R, Ding L, Lu Y, Cheung LWT, Chen K, Shaw KR, Meric-Bernstam F, Scott KL, Yi S, Sahni N, Liang H, Mills GB Cancer Cell. 2018 Mar 12;33(3):450-462.e10. doi: 10.1016/j.ccell.2018.01.021. PubMed Journal
Articles Citing pHAGE-KDR
| Articles |
|---|
| VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment. Zhang Y, Huang H, Coleman M, Ziemys A, Gopal P, Kazmi SM, Brekken RA. JCI Insight. 2021 Dec 8;6(23). pii: 150735. doi: 10.1172/jci.insight.150735. PubMed |
| Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer. Bychkov I, Topchu I, Makhov P, Kudinov A, Patel JD, Boumber Y. Cancers (Basel). 2023 Apr 28;15(9):2529. doi: 10.3390/cancers15092529. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.